| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4003356 | American Journal of Ophthalmology | 2011 | 9 Pages |
Abstract
Results of anti-tuberculosis treatment were encouraging in QuantiFERON-TB Gold-positive ocular inflammation, especially with values over 2 IU/mL in our study, suggesting that a higher cut-off value than that given by the manufacturer should be considered to better identify ocular inflammation that can benefit from full anti-tuberculosis treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Raquel Gineys, Bahram Bodaghi, Ghislaine Carcelain, Nathalie Cassoux, Le Thi Huong Boutin, Zahir Amoura, Phuc Lehoang, Salim Trad,